ArticleScientific reports2020
Reclamation of hexavalent chromium using catalytic activity of highly recyclable biogenic Pd(0) nanoparticles.
Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Environmentally sustainable renewable luffa-derived biomass graphene nanosheets for efficient Cr (VI) removal: Fabrication, characterization, and adsorption analysis.Scientific reports · 2026Article
- EXSCLAIM!: Harnessing materials science literature for self-labeled microscopy datasets.Patterns (New York, N.Y.) · 2023Article
- Nano-Biofertilizer Formulations for Agriculture: A Systematic Review on Recent Advances and Prospective Applications.Bioengineering (Basel, Switzerland) · 2023Review
- Application of polymer-coated Macadamia integrifolia nutshell biomass impregnated with palladium for chromium(VI) remediation.Scientific reports · 2021Article
- Eco-Friendly Synthesis of SnONanomaterials (Basel, Switzerland) · 2021Article
- Inorganic nanoparticles for reduction of hexavalent chromium: Physicochemical aspects.Journal of hazardous materials · 2021Review
- Phytosynthesis of Palladium Nanoclusters: An Efficient Nanozyme for Ultrasensitive and Selective Detection of Reactive Oxygen Species.Molecules (Basel, Switzerland) · 2020Article
- Enzyme Mimetic Activity of ZnO-Pd Nanosheets Synthesized via a Green Route.Molecules (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hexavalent chromium is extremely toxic and increasingly prevalent owing to industrialisation, thereby posing serious human health and environmental risks. Therefore, new approaches for detoxifying high concentrations of Cr (VI) using an ultralow amount of catalyst with high recyclability are increasingly being considered. The catalytic conversion of Cr (VI) into Cr (III) was previously reported; however, it required a large amount of catalyst to reduce a low concentration of Cr (VI); further, pH adjustment and catalyst separation had to be performed, causing issues with large-scale remediation. In this study, an unprecedented eco-friendly and cost-effective method was developed for the synthesis of Pd nanoparticles (PdNPs) with a significantly narrow size distribution of 3-25 nm. PdNPs demonstrated the presence of elemental Pd with the zero oxidation state when analysed by energy-dispersive X-ray analysis and X-ray photoelectron spectroscopy. The PdNPs could detoxify a high concentration of Cr (VI), without the need to adjust the pH or purify the nanoparticles for reusability. The reusability of the PdNPs for the catalytic conversion of Cr (VI) into Cr (III) was >90% for subsequent cycles without the further addition of formic acid. Thus, the study provides new insights into the catalytic reclamation of Cr (VI) for industrial wastewater treatment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.